Zum Inhalt springen Zur Suche springen

News-Detail

Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders.
Hajar et al., Med Res Rev. [in press]

Malak Hajar, Tobias Werner, Mihajlo Gajic, Holger Stark, Bassem Sadek.

Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders.

Med Res Rev. 2025 May 19. doi: 10.1002/med.22119. [Epub ahead of print] PubMed ID: 40384397

 

Further Information:

PubMed

Holger Stark

Kategorie/n: NND-Publikationen